Clinical Trial Update: Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S) [Phase 3]

View source ↗

Summary

Phase 3 trial CE-5S evaluating contrast-enhanced sonothrombolysis and sonolysis in ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ultrasound contrast agent (unspecified)

Snippet

Sponsor: Umeå University | Conditions: Ischemic Stroke | Phase 3 | Status: TERMINATED